Electro-acupuncture for central obesity: randomized, patient-assessor blinded, sham-controlled clinical trial protocol

Linda L D Zhong, Xingyao Wu, Tsz Fung Lam, Ying Ping Wong, Peihua Cao, Emily Yen Wong, Shipping Zhang, Zhaoxiang Bian, Linda L D Zhong, Xingyao Wu, Tsz Fung Lam, Ying Ping Wong, Peihua Cao, Emily Yen Wong, Shipping Zhang, Zhaoxiang Bian

Abstract

Background: Obesity is a common medical condition. Among all the classifications of obesity, central obesity is considered to be a significant threat on the health of individuals. Scientific researches have demonstrated that the accumulation of intra-abdominal fat is associated with higher metabolic and cardiovascular disease risks independently from Body Mass Index (BMI). Our previous research found that the combination of electro-acupuncture and auricular acupressure could significantly reduce the body weight and the BMI compared to sham control group.

Methods/design: This is a patient-assessor blinded, randomized, sham-controlled clinical trial on electro-acupuncture for central obesity. One hundred sixty-eight participants with central obesity will be randomly assigned to two groups, which are the acupuncture group and the sham control group. The whole study duration will be 8-week treatment plus 8-week follow up. The primary outcome is the change in waist circumference before and after the treatment. The secondary outcomes include the changes in hip circumference, waist-to-hip circumference ratio, BMI and body fat percentage during the treatment and follow-up.

Conclusion: The trial will evaluate the efficacy and safety of electro-acupuncture for central obesity compared with sham acupuncture. The study may provide the solid evidence of electro-acupuncture on central obesity in Hong Kong.

Trial registration: ClinicalTrials.gov Identifier: NCT03815253 ,Registered 24 Jan 2019.

Keywords: Central obesity; Efficacy and safety; Electro-acupuncture; Randomized controlled trial.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Participant flow chat

References

    1. Endalifer ML, Diress G. Epidemiology, predisposing factors, biomarkers, and prevention mechanism of obesity: a systematic review. J Obes. 2020;2020:6134362. doi: 10.1155/2020/6134362.
    1. NCD Risk Factor Collaboration (NCD-RisC) Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–2642. doi: 10.1016/S0140-6736(17)32129-3.
    1. Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021;9(6):373–392. doi: 10.1016/S2213-8587(21)00045-0.
    1. Centre for Health Protection HKS. Population health survey report body of Hong Kong. Available from: . Accessed 22 Dec 2019.
    1. Lehnert T, Streltchenia P, Konnopka A, Riedel-Heller SG, König H-H. Health burden and costs of obesity and overweight in Germany: an update. Eur J Health Econ. 2015;16(9):957–967. doi: 10.1007/s10198-014-0645-x.
    1. Cawley J, Meyerhoefer C. The medical care costs of obesity: an instrumental variables approach. J Health Econ. 2012;31(1):219–230. doi: 10.1016/j.jhealeco.2011.10.003.
    1. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity. 2008;16(10):2323–2330. doi: 10.1038/oby.2008.351.
    1. Jin Wensheng PC. Global understanding of the definition of metabolic syndrome in the international diabetes Alliance. Chin J Endocr Metab. 2005;21(4):412–413.
    1. Zhu S, Wang Z, Heshka S, Heo M, Faith MS, Heymsfield SB. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr. 2002;76(4):743. doi: 10.1093/ajcn/76.4.743.
    1. Wittchen H-U, Balkau B, Massien C, Richard A, Haffner S, Després J-P. International day for the evaluation of abdominal obesity: rationale and design of a primary care study on the prevalence of abdominal obesity and associated factors in 63 countries. Eur Heart J Suppl. 2006;8(suppl_B):B26–B33. doi: 10.1093/eurheartj/sul005.
    1. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study. Lancet. 2005;366(9497):1640–1649. doi: 10.1016/S0140-6736(05)67663-5.
    1. Zhang C, Rexrode KM, Van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality. Circulation. 2008;117(13):1658–1667. doi: 10.1161/CIRCULATIONAHA.107.739714.
    1. Tsujimoto T, Kajio H. Abdominal obesity is associated with an increased risk of all-cause mortality in patients with HFpEF. J Am Coll Cardiol. 2017;70(22):2739–2749. doi: 10.1016/j.jacc.2017.09.1111.
    1. Sala M, de Roos A, van den Berg A, Altmann-Schneider I, Slagboom PE, Westendorp RG, van Buchem MA, de Craen AJM, van der Grond J. Microstructural brain tissue damage in metabolic syndrome. Diabetes Care. 2014;37(2):493–500. doi: 10.2337/dc13-1160.
    1. Razay G, Vreugdenhil A, Wilcock G. Obesity, abdominal obesity and Alzheimer disease. Dement Geriatr Cogn Disord. 2006;22(2):173–176. doi: 10.1159/000094586.
    1. Dong Y, Zhou J, Zhu Y, Luo L, He T, Hu H, et al. Abdominal obesity and colorectal cancer risk: systematic review and meta-analysis of prospective studies. Biosci Rep. 2017;37(6):BSR20170945. doi: 10.1042/BSR20170945.
    1. Du X, Hidayat K, Shi B-M. Abdominal obesity and gastroesophageal cancer risk: systematic review and meta-analysis of prospective studies. Biosci Rep. 2017;37(3):BSR20160474. doi: 10.1042/BSR20160474.
    1. Dhaliwal SS, Welborn TA. Central obesity and cigarette smoking are key determinants of cardiovascular disease deaths in Australia: a public health perspective. Prev Med. 2009;49(2–3):153–157. doi: 10.1016/j.ypmed.2009.07.019.
    1. Kesztyus D, Erhardt J, Schonsteiner D, Kesztyus T. Therapeutic treatment for abdominal obesity in adults. Dtsch Arztebl Int. 2018;115(29–30):487–493. doi: 10.3238/arztebl.2018.0487.
    1. Dombrowski SU, Avenell A, Sniehott FF. Behavioural interventions for obese adults with additional risk factors for morbidity: systematic review of effects on behaviour, weight and disease risk factors. Obes Facts. 2010;3(6):377–396. doi: 10.1159/000323076.
    1. Ioannides-Demos LL, Proietto J, Tonkin AM, McNeil JJ. Safety of drug therapies used for weight loss and treatment of obesity. Drug Saf. 2006;29(4):277–302. doi: 10.2165/00002018-200629040-00001.
    1. Sidhaye A, Cheskin LJ. Pharmacologic treatment of obesity. Health and Treatment Strategies in Obesity. 27: Karger Publishers; 2006. pp. 42–52.
    1. Lingling YU, Zhixiong WU. Clinical observation of traditional Chinese medicine fumigation combined with functional exercise in treatment of shoulder-hand syndrome. Pharmacy Today; 2015.
    1. Xu L, Ding C, Chen J, Tan R, Chen D, Xu S, et al. Efficacy difference between warming acupuncture and other acupuncture methods for primary obesity: a meta-analysis. Zhongguo Zhen Jiu. 2018;38(9):1019–1026.
    1. Sui Y, Zhao HL, Wong VC, Brown N, Li XL, Kwan AK, et al. A systematic review on use of Chinese medicine and acupuncture for treatment of obesity. Obes Rev. 2012;13(5):409–430. doi: 10.1111/j.1467-789X.2011.00979.x.
    1. Cho S, Lee J, Thabane L, Lee J. Acupuncture for obesity: a systematic review and meta-analysis. Int J Obes. 2009;33(2):183–196. doi: 10.1038/ijo.2008.269.
    1. Zhang RQ, Tan J, Li FY, Ma YH, Han LX, Yang XL. Acupuncture for the treatment of obesity in adults: a systematic review and meta-analysis. Postgrad Med J. 2017;93(1106):743–751. doi: 10.1136/postgradmedj-2017-134969.
    1. Zhong LL, Kun W, Lam TF, Zhang SP, Yang JJ, Ziea TC, et al. The combination effects of body acupuncture and auricular acupressure compared to sham acupuncture for body weight control: study protocol for a randomized controlled trial. Trials. 2016;17(1):346. doi: 10.1186/s13063-016-1458-2.
    1. Choi D, Choi S, Son JS, Oh SW, Park SM. Impact of discrepancies in general and abdominal obesity on major adverse cardiac events. J Am Heart Assoc. 2019;8(18):e013471. doi: 10.1161/JAHA.119.013471.
    1. Rankinen T, Kim SY, Perusse L, Despres JP, Bouchard C. The prediction of abdominal visceral fat level from body composition and anthropometry: ROC analysis. Int J Obes Relat Metab Disord. 1999;23(8):801–809. doi: 10.1038/sj.ijo.0800929.
    1. Lin LL, Wang LQ, Yang JW, Tu JF, Wang TQ, Liu CZ, et al. Researches status on time-effect of acupuncture. Zhongguo Zhen Jiu. 2019;39(05):565–570.
    1. He W, Zhu B, Yu XC, Liu BY, Xu NG, Jing XH. Comparison betwen western and Chinese acupuncture and its enlightenment. Zhongguo Zhen Jiu. 2015;35(2):105–108.
    1. MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White A, Moher D, on behalf of the STRICTA Revision Group Revised STandards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement. PLoS Med. 2010;7(6):e1000261. doi: 10.1371/journal.pmed.1000261.
    1. Park JE, Ryu YH, Liu Y, Jung HJ, Kim AR, Jung SY, Choi SM. A literature review of de qi in clinical studies. Acupunct Med. 2013;31(2):132–142. doi: 10.1136/acupmed-2012-010279.
    1. The Dudley Group (Nutirtion and Dietetics Department). NHS Patient sheets on carbonydrafte counting tables. . Accessed 31 Jan 2021.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir